Atlas Trials

Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)

Clinical trial NCT02759354 · COMPLETED

Trial details

NCT number
NCT02759354
Sponsor
MCM Vaccines B.V.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis BPertussis
Start date
2016-04-26
Primary completion
2016-07-29
Enrollment
754

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.